Literature DB >> 33536877

HMGA1 Induction of miR-103/107 Forms a Negative Feedback Loop to Regulate Autophagy in MPTP Model of Parkinson's Disease.

Gehui Li1,2, Wanxian Luo3, Baoyan Wang1, Chen Qian1, Yongyi Ye4, Yuantao Li2, Shizhong Zhang1.   

Abstract

Autophagy dysfunction has been directly linked with the onset and progression of Parkinson's disease (PD), but the underlying mechanisms are not well understood. High-mobility group A1 (HMGA1), well-known chromatin remodeling proteins, play pivotal roles in diverse biological processes and diseases. Their function in neural cell death in PD, however, have not yet been fully elucidated. Here, we report that HMGA1 is highly induced during dopaminergic cell death in vitro and mice models of PD in vivo. Functional studies using genetic knockdown of endogenous HMGA1 show that HMGA1 signaling inhibition accelerates neural cell death, at least partially through aggravating MPP+-induced autophagic flux reduction resulting from partial block in autophagic flux at the terminal stages, indicating a novel potential neuroprotective role for HMGA1 in dopaminergic neurons death. MicroRNA-103/107 (miR-103/107) family, which is highly expressed in neuron, coordinately ensures proper end-stage autophagy. We further illustrate that MPP+/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced HMGA1 elevation counterparts the effect of miR-103/107 downregulation by directly binding to their promoters, respectively, sustaining their expression in MPP+-damaged MN9D cells and modulates autophagy through CDK5R1/CDK5 signaling pathway. We also find that HMGA1 is a direct target of miR-103/107 family. Thus, our results suggest that HMGA1 forms a negative feedback loop with miR-103/107-CDK5R1/CDK5 signaling to regulate the MPP+/MPTP-induced autophagy impairment and neural cell death. Collectively, we identify a paradigm for compensatory neuroprotective HMGA1 signaling in dopaminergic neurons that could have important therapeutic implications for PD.
Copyright © 2021 Li, Luo, Wang, Qian, Ye, Li and Zhang.

Entities:  

Keywords:  HMGA1; Parkinson’s disease; autophagy; dopaminergic neuron; miR-103/107

Year:  2021        PMID: 33536877      PMCID: PMC7847849          DOI: 10.3389/fncel.2020.620020

Source DB:  PubMed          Journal:  Front Cell Neurosci        ISSN: 1662-5102            Impact factor:   5.505


  4 in total

Review 1.  High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.

Authors:  Lu Wang; Ji Zhang; Min Xia; Chang Liu; Xuyu Zu; Jing Zhong
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

2.  Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.

Authors:  Jing Zhang; Bohao Sun; Jifeng Yang; Zhuo Chen; Zhengzheng Li; Nan Zhang; Hongzhi Li; Luxi Shen
Journal:  Mol Med Rep       Date:  2022-01-18       Impact factor: 2.952

Review 3.  The Role of Non-Coding RNAs in the Pathogenesis of Parkinson's Disease: Recent Advancement.

Authors:  Hanwen Zhang; Longping Yao; Zijian Zheng; Sumeyye Koc; Guohui Lu
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-30

4.  A novel risk score model based on fourteen chromatin regulators-based genes for predicting overall survival of patients with lower-grade gliomas.

Authors:  Yongfeng Zhang; Beibei Yu; Yunze Tian; Pengyu Ren; Boqiang Lyu; Longhui Fu; Huangtao Chen; Jianzhong Li; Shouping Gong
Journal:  Front Genet       Date:  2022-09-26       Impact factor: 4.772

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.